Division of Clinical Research, National Health Research Institutes, Zhunan, Taiwan.
PLoS One. 2007 Aug 15;2(8):e719. doi: 10.1371/journal.pone.0000719.
Most traditional Chinese herbal formulas consist of at least four herbs. Four-Agents-Decoction (Si Wu Tang) is a documented eight hundred year old formula containing four herbs and has been widely used to relieve menstrual discomfort in Taiwan. However, no specific effect had been systematically evaluated. We applied Western methodology to assess its effectiveness and safety for primary dysmenorrhoea and to evaluate the compliance and feasibility for a future trial.
METHODOLOGY/PRINCIPAL FINDINGS: A randomised, double-blind, placebo-controlled, pilot clinical trial was conducted in an ad hoc clinic setting at a teaching hospital in Taipei, Taiwan. Seventy-eight primary dysmenorrheic young women were enrolled after 326 women with self-reported menstrual discomfort in the Taipei metropolitan area of Taiwan were screened by a questionnaire and subsequently diagnosed by two gynaecologists concurrently with pelvic ultrasonography. A dosage of 15 odorless capsules daily for five days starting from the onset of bleeding or pain was administered. Participants were followed with two to four cycles for an initial washout interval, one to two baseline cycles, three to four treatment cycles, and three follow-up cycles. Study outcome was pain intensity measured by using unmarked horizontal visual analog pain scale in an online daily diary submitted directly by the participants for 5 days starting from the onset of bleeding or pain of each menstrual cycle. Overall-pain was the average pain intensity among days in pain and peak-pain was the maximal single-day pain intensity. At the end of treatment, both the overall-pain and peak-pain decreased in the Four-Agents-Decoction (Si Wu Tang) group and increased in the placebo group; however, the differences between the two groups were not statistically significant. The trends persisted to follow-up phase. Statistically significant differences in both peak-pain and overall-pain appeared in the first follow-up cycle, at which the reduced peak-pain in the Four-Agents-Decoction (Si Wu Tang) group did not differ significantly by treatment length. However, the reduced peak-pain did differ profoundly among women treated for four menstrual cycles (2.69 (2.06) cm, mean (standard deviation), for the 20 women with Four-Agents-Decoction and 4.68 (3.16) for the 22 women with placebo, p = .020.) There was no difference in adverse symptoms between the Four-Agents-Decoction (Si Wu Tang) and placebo groups.
CONCLUSION/SIGNIFICANCE: Four-Agents-Decoction (Si Wu Tang) therapy in this pilot post-market clinical trial, while meeting the standards of conventional medicine, showed no statistically significant difference in reducing menstrual pain intensity of primary dysmenorrhoea at the end of treatment. Its use, with our dosage regimen and treatment length, was not associated with adverse reactions. The finding of statistically significant pain-reducing effect in the first follow-up cycle was unexpected and warrants further study. A larger similar trial among primary dysmenorrheic young women with longer treatment phase and multiple batched study products can determine the definitive efficacy of this historically documented formula.
Controlled-Trials.com ISRCTN23374750.
大多数传统中药方剂至少由四味草药组成。四物汤(四味汤)是一种有八百多年历史的方剂,由四味草药组成,在台湾被广泛用于缓解月经不适。然而,尚未对其具体疗效进行系统评估。我们应用西方方法学评估其对原发性痛经的有效性和安全性,并评估其在未来试验中的依从性和可行性。
方法/主要发现:在台北一家教学医院的专门诊所进行了一项随机、双盲、安慰剂对照、初步临床试验。在对台湾都会区的 326 名有自我报告月经不适的女性进行问卷调查和随后由两位妇科医生同时进行盆腔超声检查后,招募了 78 名原发性痛经的年轻女性。从出血或疼痛开始,每天服用 15 粒无味胶囊,连续服用 5 天。参与者在初始洗脱期、1 至 2 个基线期、3 至 4 个治疗期和 3 个随访期进行随访。研究结果是通过参与者直接在线提交的无标记水平视觉模拟疼痛量表在每个月经周期出血或疼痛开始后的 5 天内每天测量的疼痛强度。总体疼痛是疼痛日的平均疼痛强度,峰值疼痛是单日最大疼痛强度。治疗结束时,四物汤组的总体疼痛和峰值疼痛均降低,安慰剂组则升高;然而,两组之间的差异无统计学意义。这一趋势在随访阶段仍在持续。在第一个随访周期中,峰值疼痛和总体疼痛均出现统计学显著差异,四物汤组的峰值疼痛降低,但与治疗时间长短无关。然而,接受四个月经周期治疗的女性之间的峰值疼痛差异显著(四物汤组 20 名女性的平均(标准差)为 2.69(2.06)cm,安慰剂组 22 名女性为 4.68(3.16)cm,p=0.020)。四物汤组和安慰剂组之间的不良反应无差异。
结论/意义:在这项初步上市后临床试验中,四物汤疗法符合常规医学标准,但在治疗原发性痛经的结束时,并未显示出在减轻月经疼痛强度方面有统计学意义的差异。在我们的剂量方案和治疗时间范围内,它的使用与不良反应无关。在第一个随访周期中发现的统计学显著的疼痛减轻效果出乎意料,值得进一步研究。在原发性痛经的年轻女性中进行更大规模的类似试验,延长治疗阶段并采用多批研究产品,可以确定该历史记录配方的明确疗效。
controlled-trials.com ISRCTN23374750。